Benzoate-grown cells of Pseudomonas putida(arvilla) mt-2 contain both metapyrocatechase and pyrocatechase activities, although the former activity is much higher than that of the latter. A spontaneous mutant deficient in metapyrocatechase and 2-hydroxymuconic semialdehyde hydrolyase, the first two enzymes in the meta-cleavage pathway of the ring of catechol, has been isolated from this strain. This mutant grows well on a minimal medium containing benzoate as a sole carbon source and has the high activity of pyrocatechase. These findings indicate that the strain mt-2 possesses the genetic capacity for enzymes of both the meta-and ortho-cleavage pathways of benzoate degradation, but its phenotypic expression is the meta pathway.
A fluorescent pseudomonad designated as Pseudomonas putida(arvilla) mt-2 (7) was used by Nozaki et al. (17) as a source for crystallization of metapyrocatechase (catechol 2,3-oxygenase; EC 1.13.1.2), which catalyzes the oxygenative cleavage of the ring of catechol to form 2-hydroxymuconic semialdehyde (HMS). According to an extensive taxonomic analysis of the fluorescent pseudomonads by Stanier et al. (20) , P. putida(arvilla) mt-2 is a typical representative of the species P. putida biotype A. It differs, however, from other members of this species in the nature of its pathway for the benzoate metabolism. Whereas most strains of this species degrade catechol by the orthocleavage pathway, strain mt-2 decomposes benzoate through the meta-cleavage pathway (Fig. 1) . Although strain mt-2 has been reported to contain no pyrocatechase (catechol 1,2-oxygenase; EC 1.13.1.1) (7), the assay for pyrocatechase in the presence of high levels of metapyrocatechase seemed to require some caution, since these two enzymes attack the same substrates, catechol and oxygen.
In this paper we present evidence indicating that benzoate-grown cells of P. putida(arvilla) mt-2 do contain pyrocatechase. The presence of pyrocatechase in wild-type cells was demonstrated by the selective inactivation of metapyrocatechase and the isolation of a mutant which possesses no meta-cleavage pathway, but does possess the ortho-cleavage pathway.
MATERIALS AND METHODS Bacterial strains. P. putida(arvilla) mt-2 (ATCC 23973) was supplied by M. Nozaki, Department of Medical Chemistry, Kyoto University, Kyoto, Japan. Mutant P 100 was obtained spontaneously from the strain mt-2 as a metapyrocatechase-deficient mutant (see Results). Mutant P 111, which is unable to grow on benzoate as a sole carbon source, was isolated from P 100 as described below. The identity of these strains as P. putida was established by examining the Gram reaction, motility, microscopic morphology, ability to produce fluorescent pigment, growth at 42 C, "egg yolk" reaction, and denitrification (20) .
Media. Minimal medium M9 without carbon sources (3) was supplemented with 0.2% sodium benzoate and 0.05% yeast extract (Difco Laboratories, Detroit, Mich.; BY medium). L broth (11) was used in some experiments as a rich medium. Nutrient agar (Eiken Chemical Co. Ltd., Tokyo, Japan) was supplemented with 0.2% sodium benzoate where indicated (BN agar). The M9 medium containing 1.5% agar (Eiken) was supplemented with either 1% glucose and 0.4% sodium benzoate (GB agar) or 0.2% sodium benzoate (B agar).
Culture conditions and preparation of extracts. The cells were grown at 27 C with shaking for 18 h in BY medium. Cultures were harvested by centrifugation, and the cells were washed once with 0.05 M potassium phosphate buffer (pH 7.5). Cells were suspended in this buffer at a density of 7 x 109 to 10o0 cells per ml and disintegrated for 1 min in an ice bath with a 20 kc probe-type Tomy sonic oscillator, model UR 105 P (Tomy Seiko Co. Ltd., Tokyo, Japan). The preparation was centrifuged at 12,000 x g for 20 min at 0 C to remove whole cells and large debris.
TWO BENZOATE PATHWAYS IN P. PUTIDA mt-2 Enzyme assays. Enzyme assays were performed at 27 C with a Hitachi Perkin-Elmer spectrophotometer, model 139 (Hitachi Ltd., Tokyo, Japan). All measurements were made in cuvettes with a 1-cm light path in a total volume of 3.0 ml.
Metapyrocatechase was assayed by measuring the rate of formation of HMS (16) . Cell-free extracts were prepared in phosphate buffer containing 10% acetone to stabilize the enzyme (17) . The reaction mixture contained 0.05 M potassium phosphate buffer (pH 7.5), 0.33 mM catechol, and appropriately diluted cell-free extracts. A 1-Amol amount of HMS gives an optical density of 14.7 at 375 nm under these conditions (16) .
HMS hydrolyase was determined by measuring the rate of decrease in the absorbance at 375 nm as the strongly absorbing substrate was converted to nonabsorbing products. The substrate for this reaction was produced in a cuvette by the incubation of 34 gg of crystalline metapyrocatechase (kindly supplied by M. Nozaki) with 33 MM cateehol in 3 ml of 0.05 M potassium phosphate buffer (pH 7.5). After the reaction was completed, a sample of cell-free extract was added to the mixture, and the time course of the reaction was followed.
Pyrocatechase was assayed by measuring the rate of formation of cis,cis-muconate (14) . Cell-free extracts were prepared in phosphate buffer without acetone. The reaction mixture contained 0.05 M potassium phosphate buffer (pH 7.5), 0.33 mM catechol, and cell-free extracts. The activity of pyrocatechase in the extracts of metapyrocatechase-deficient mutants was determined by the addition of the extracts directly to the reaction mixture. To measure the enzyme activity in the extracts containing high levels of metapyrocatechase, cell-free extracts were treated with H202 before assay (see Results). The conversion of 1 Mmol of catechol to cis, cis-muconate causes an increase in the absorbance at 260 nm of 5.33 optical density units (14) .
One unit of these enzyme activities was defined as that which catalyzes either the formation of 1 Mmol of the product or the degradation of 1 Mmol of the substrate per min. Protein concentrations were determined by the biuret method with bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) as a standard (10) . The specific activity was defined as 1 unit of enzyme activity per milligram of protein.
Fluctuation analysis. The fluctuation analysis was performed by the method of Luria and Delbriick (12) . An overnight culture of the strain mt-2 in L broth was diluted in saline to 1.5 x 102 cells per ml. Then 0.1-ml portions were transferred into 11 identical tubes containing 5 ml of L broth. After incubation at 27 C for 15 h with shaking, cultures were diluted with saline. A 0.1-ml portion of 10-2 dilutions was spread on GB agar for the determination of mutants, while a 0.1-ml portion of 10-i dilutions was spriead on nutrient agar for the determination of viable cells. To test the reliability of the plating method, 10 identical tubes of 10-2 dilutions were made from one inoculum, and a 0.1-ml portion from each tube was spread on GB agar. The mutation rate was calculated by the formula; r = aNtln(NtCa), where r, a, N,, and C represent an average of the number of mutants in samples, the mutation rate, the number of bacteria in a sample, and the number of samples, respectively (12) . Elimination experiments. The effect of "curing" drugs on the mutation frequency was examined as follows. An overnight culture of strain mt-2 in L broth was diluted to 2 x 103 cells per ml in L broth. A 0.5-ml portion was transferred into 5 ml of L broth (pH 7.6) without or with either 50 Mug of acridine orange per ml, 10% (wt/vol) sodium dodecyl sulfate, or 1 mM ethidium bromide. After incubation at 27 C for 24 h with shaking, cells were plated on both GB agar and nutrient agar after appropriate dilutions in saline.
Mutagenesis and selection of benzoate-nondegradative mutants. N-Methyl-N'-nitro-N-nitrosoguanidine (Daiichi Pure Chemicals Co. Ltd., Tokyo, Japan) was used at a final concentration of 150 Mg/ ml in 0.1 M sodium citrate buffer (pH 5.5). D-Cycloserine screening was carried out as described by Curtiss et al. (4) . After the treatment of the strain P 100 with the mutagen at 27 C for 90 min, the cells were washed once with and resuspended in 10 ml of M9 medium supplemented with 1% sodium citrate. Af 
RESULTS
Demonstration of pyrocatechase in P. putida(arvilla) mt-2. Since pyrocatechase and metapyrocatechase share the common substrates, catechol and oxygen, the former activity, even if present in the extracts of P. putida (arvilla) mt-2, might not be detected because of the competition of high levels of the latter. In addition, the strongly light-absorbing product of the latter reaction might interfere with the spectrophotometric assay of the former. It has been established that the active form of iron in metapyrocatechase is in a ferrous state and the enzyme activity is quantitatively inactivated by H202 due to the conversion of the active form to the inactive ferric form (18) . In contrast, the active form of pyrocatechase is ferric and thus resistant to the oxidant (15) . Metapyrocatechase, therefore, could be selectively inactivated before carrying out an assay of pyrocatechase.
When the cell-free extract of the strain mt-2 grown in BY medium was treated with 40 mM H202, more than 99% of metapyrocatechase was inactivated (Table 1) . On the other hand, the (Fig. 2) . The possibility of the oxidative conversion of metapyrocatechase to pyrocatechase was excluded, since a completely inactivated preparation of crystalline metapyrocatechase by H202 had no activity of pyrocatechase. Above findings may indicate that the benzoategrown cells of P. putida(arvilla) mt-2 contain pyrocatechase in addition to metapyrocatechase, which is in contrast to the results of Feist and Hegeman (7) .
Isolation of a mutant defective in the metacleavage pathway. The strain mt-2 forms yellow colonies due to the accumulation of HMS when grown on BN agar. We found that a few brown colonies appeared among the numerous yellow colonies on this plate. The brown colonies were picked up and purified twice by streaking on nutrient agar plates, one of which was designated as P 100. Mutant P 100 and the wild type of the strain mt-2 were grown in BY medium, and cell-free extracts were prepared. In Table 2 are shown the specific activities of metapyrocatechase, HMS hydrolyase, and pyrocatechase in these extracts. Mutant P 100 bThe minimum detectable levels of activity are indicated by the less-than-or-equal-to signs (<).
contained no detectable level of either metapyrocatechase or HMS hydrolase, the first two enzymes concerned in the meta cleavage of the ring of catechol. On the other hand, the activity of pyrocatechase in P 100 was much higher than that of the wild-type strain. More than five clones which formed brown colonies on BN agar were selected, and the enzyme activities were determined in the extracts, all of which gave the same results as P 100. Although P 100 had no enzyme activity concerned in the meta-cleavage pathway, it grew much better than the wildtype strain in the M9 medium containing benzoate as a sole carbon source (Table 3) . Thus, it was reasonable to conclude that benzoate is degraded through the ortho-cleavage pathway in mutants defective in the enzymes of the meta-cleavage pathway.
Analysis of the meta-cleavage-deficient mutation. To analyze the mutation of the deficiency of the meta-cleavage pathway more precisely, a selection medium for mutants was sought. In Table 3 are shown the effects of benzoate on the growth of the wild type and P 100 of the strain mt-2. It is evident that the growth of the wild type in M9 medium containing 0.2% sodium benzoate as a sole carbon source was much slower than that of P 100. Furthermore, the growth of the wild type on glucose was inhibited by the addition of benzoate more severely than that of strain P 100. The addition of benzoate to M9 medium containing citrate completely inhibited the growth of both strains. GB agar which contains 1% glucose and 0.4% sodium benzoate was chosen for the selection of the meta-cleavage-deficient mutants. In Fig. 3 are shown large and small colonies on a GB plate which correspond to the mutant and the wild-type cells of the strain mt-2, respectively.
To establish that the observed mutation is really a spontaneous one, a fluctuation analysis was performed. The number of mutants appearing on plates of GB agar fluctuated widely from tube to tube (x2 = 164, where X2 = Z(Xi -_) 2/5Z
In the control experiment in which samples were plated from a single culture, the narrow statistical distribution of about the mean (x2 = 3.6) was observed. The mutation rate was calculated to be 4.2 x 10-4 mutations per bacterium per generation. The mutation rate was not accelerated by the addition of acridine orange, sodium dodecyl sulfate, or ethidium bromide.
Mutant P 100 was stable during 20 successive transfers on solid media. To determine whether the spontaneous mutation in P 100 is a singlesite mutation or a deletion, further mutants were isolated from P 100 which were unable to grow on benzoate. Strain P 111, one of these mutants lacking pyrocatechase, was tested for its ability to revert spontaneously. Spontaneous revertants appeared on B agar with the reversion frequency of 3 x 10-9, but none of these formed yellow colonies on BN agar. Therefore, these revertants regained the ability to grow on benzoate using the ortho pathway like P 100, the parent strain from which P 111 was derived. Thus, the spontaneous mutation from mt-2 to P 100 was tentatively assumed to be a deletion mutation. DISCUSSION It has occasionally been reported that some strains of the fluorescent pseudomonad capable of decomposing naphthalene, salicylate, benzenesulfonate, and/or phenol by the meta-cleavage pathway decompose benzoate through the ortho-cleavage pathway (1, 5, 6) . These observations were interpreted to mean that these strains possess the genetic capability to decompose catechol through both the meta-and ortho-cleavage pathways and that the phenotypic expression is determined by the chemical nature of the aromatic precursor with which the organisms are grown (6) .
The strain mt-2 of P. putida(arvilla) is an exception since this fluorescent pseudomonad decomposes catechol through the meta-cleavage pathway even though grown on benzoate. Evidence is presented in this paper indicating that strain mt-2 has both the ortho and meta pathways genetically, but the phenotypic expression of the former is repressed. These results are consistent with the recent report by Murray et al. (13) which provides further evidence for the operation of the ortho pathway in the mt-2 strain.
Regulation of the synthesis of the enzymes of the ortho pathway has been studied in strains P. putida (19) and P. aeruginosa (9), which degrade catechol exclusively through the ortho pathway. In both cases, it has been shown that pyrocatechase is product induced by cis, cismuconate and that catechol itself is not an inducer. Accordingly, when such strains are grown at the expense of benzoate, the induction of pyrocatechase results from the intracellular accumulation of cis, cis-muconate, which is formed metabolically from catechol through the basal activity of the oxygenase. The enzymes of the meta pathway, however, are induced by the primary substrate, cresols or phenol in P. putida (6) . It has also been reported that catechol and HMS cannot serve as functional inducers of the meta pathway in P. putida (7) .
It is possible, therefore, to explain the repression of the ortho pathway in strain mt-2 on the basis of the differences in the mode of regulation of these two pathways. When cells are grown on benzoate, the meta pathway is induced by benzoate, and catechol is degraded mainly through this pathway. Accordingly, cis, cismuconate does not accumulate enough to induce pyrocatechase. In contrast, the loss of the meta pathway in P 100 causes the accumulation of catechol and cis, cis-muconate as well, which leads to the induction of pyrocatechase (Table  2) .
It is of interest that, although the specific activity of metapyiocatechase in the wild-type strain is higher than that of pyrocatechase in mutant P 100, the mutant grows much better than the wild type on a medium containing benzoate as a sole carbon source (Table 3) . One possible explanation for this finding is that the benzoate oxygenase system which catalyzes the conversion of benzoate to catechol is repressed somehow in the wild-type strain.
A similar complete shift from use of the meta pathway to the ortho pathway to that caused by the mutation of mt-2 to P 100 was observed by Feist and Hegeman while studying phenol degradation through the meta pathway by P. putida U (6) . A mutant unable to grow on phenol yielded a revertant which is able to grow on phenol but uses the ortho pathway. In their case, the revertant is derived from the wild-type P. putida U by two mutational events, while P 100 is derived from P. putida(arvilla) mt-2 by a single spontaneous mutation.
The fact that none of the spontaneous revertants derived from P 111, a pyrocatechase-deficient mutant, possesses the meta pathway suggests that the mutation in P 100 is a deletion rather than a point mutation. No detection of HMS hydrolyase could not be attributable to a secondary event accompanied by a loss of metapyrocatechase, since the hydrolyase has been shown to be induced not by the substrate but by benzoate itself (7) . Thus, the simultaneous loss of these two enzymes in P 100 might also suggest a deletion of the genes specifying the enzymes of the meta pathway, which may exist as a gene cluster.
Recently, after this study had been completed, Chakrabarty (2) reported that the genes of the meta-cleavage pathway concerning in the degradation of salicylate in P. putida Rl exist on an extrachromosomal element and that the loss of the salicylate gene cluster is enhanced only by mitomycin C but not by other curing drugs such as acridine orange, acriflavine, or sodium dodecyl sulfate. It seems possible, therefore, that the gene cluster of the meta-cleavage pathway of benzoate degradation in P. putida (arvilla) mt-2 may also exist as a plasmid. The high spontaneous mutation rate observed by the fluctuation analysis for the spontaneous meta pathway mutants is further suggestive of plasmid loss. 
